Taking into account past and present findings, the combination of BPSD, APOE carrier status and circadian genotypes could be a useful strategy to identify the most vulnerable patients with cognitive impairments to dementia conversion and also to apply early psychological interventions based on genetic findings in AD patients that present with specific BPSD. This evidence concerns the gene APOE and Cognitive impairment.